Biotechnology firm Oxford Nanopore (LON:ONT) maintained its forecasts for the next couple of years after positive H1 trading. Importantly for investors, the company said it was ‘tracking well’ towards its target of adjusted EBITDA breakeven in FY27. Positive H1 progress For the six months to June, the firm posted a 10.5% increase in revenue to … Continue reading Oxford Nanopore maintains forecasts after H1 progress